[go: up one dir, main page]

DE69830301D1 - Modulatoren von insulinrezeptor-aktivität - Google Patents

Modulatoren von insulinrezeptor-aktivität

Info

Publication number
DE69830301D1
DE69830301D1 DE69830301T DE69830301T DE69830301D1 DE 69830301 D1 DE69830301 D1 DE 69830301D1 DE 69830301 T DE69830301 T DE 69830301T DE 69830301 T DE69830301 T DE 69830301T DE 69830301 D1 DE69830301 D1 DE 69830301D1
Authority
DE
Germany
Prior art keywords
insulin receptor
stimulates
independently
insulin
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69830301T
Other languages
English (en)
Other versions
DE69830301T2 (de
Inventor
M Kauvar
Richard Sportsman
O Villar
R Spevak
A Kohanski
Apparao Satyam
Ryan Koehler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Telik Inc
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/784,854 external-priority patent/US5851988A/en
Priority claimed from US08/784,857 external-priority patent/US5830918A/en
Priority claimed from US08/916,088 external-priority patent/US6329431B1/en
Application filed by Telik Inc filed Critical Telik Inc
Application granted granted Critical
Publication of DE69830301D1 publication Critical patent/DE69830301D1/de
Publication of DE69830301T2 publication Critical patent/DE69830301T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/33—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of six-membered aromatic rings being part of condensed ring systems
    • C07C309/34—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of six-membered aromatic rings being part of condensed ring systems formed by two rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69830301T 1997-01-15 1998-01-15 Modulatoren von insulinrezeptor-aktivität Expired - Fee Related DE69830301T2 (de)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US784857 1985-10-04
US784854 1991-10-30
US78485597A 1997-01-15 1997-01-15
US784855 1997-01-15
US08/784,854 US5851988A (en) 1997-01-15 1997-01-15 Nonpeptide insulin receptor agonists
US08/784,857 US5830918A (en) 1997-01-15 1997-01-15 Nonpeptide insulin receptor agonists
US82526997A 1997-03-27 1997-03-27
US825269 1997-03-27
US08/916,088 US6329431B1 (en) 1997-01-15 1997-08-21 Nonpeptide insulin receptor agonists
US916088 1997-08-21
PCT/US1998/000801 WO1998032017A2 (en) 1997-01-15 1998-01-15 Modulators of insulin receptor activity

Publications (2)

Publication Number Publication Date
DE69830301D1 true DE69830301D1 (de) 2005-06-30
DE69830301T2 DE69830301T2 (de) 2006-02-02

Family

ID=27542207

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69830301T Expired - Fee Related DE69830301T2 (de) 1997-01-15 1998-01-15 Modulatoren von insulinrezeptor-aktivität

Country Status (9)

Country Link
EP (1) EP0960335B1 (de)
JP (1) JP2002512685A (de)
AT (1) ATE296446T1 (de)
AU (1) AU6026698A (de)
CA (1) CA2278023A1 (de)
DE (1) DE69830301T2 (de)
DK (1) DK0960335T3 (de)
ES (1) ES2242995T3 (de)
WO (1) WO1998032017A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875741B2 (en) * 1998-09-02 2005-04-05 Renuka Pillutla Insulin and IGF-1 receptor agonists and antagonists
CA2343934A1 (en) 1998-09-25 2000-04-06 The Children's Medical Center Corporation Short peptides which selectively modulate the activity of protein kinases
TWI234557B (en) * 1999-05-26 2005-06-21 Telik Inc Novel naphthalene ureas as glucose uptake enhancers
WO2000073793A2 (en) * 1999-05-27 2000-12-07 Cecil Yip Identification of compounds modulating insulin receptor activity
EA006704B1 (ru) * 1999-07-29 2006-02-24 Телик, Инк. Нафтилсульфоновые кислоты и родственные соединения в качестве агонистов поглощения глюкозы
FR2797767B1 (fr) * 1999-08-27 2002-06-14 Centre Nat Rech Scient Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
EP2368902A3 (de) * 2000-03-29 2011-12-21 DGI Bio Technologies LLC Agonisten und antagonisten der rezeptoren des insulin und des igf-1
US20050170343A1 (en) * 2001-01-12 2005-08-04 Cynthnia Seidel-Dugan Modulating insulin receptor signaling
CN1658849A (zh) * 2002-06-05 2005-08-24 株式会社医药分子设计研究所 Ap－1和nfat活化抑制剂
CA2488342A1 (en) * 2002-06-05 2003-12-18 Institute Of Medicinal Molecular Design, Inc. Therapeutic drug for diabetes
US7626042B2 (en) 2002-06-06 2009-12-01 Institute Of Medicinal Molecular Design, Inc. O-substituted hydroxyaryl derivatives
WO2003103665A1 (ja) * 2002-06-06 2003-12-18 株式会社医薬分子設計研究所 抗アレルギー薬
WO2003103655A1 (ja) * 2002-06-10 2003-12-18 株式会社医薬分子設計研究所 癌治療剤
EA010470B1 (ru) * 2002-06-10 2008-08-29 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. ИНГИБИТОРЫ АКТИВАЦИИ NF-kB
DE10323081A1 (de) * 2003-05-22 2004-12-16 Aventis Pharma Deutschland Gmbh Verwendung eines Polypeptides
EP1885855A4 (de) * 2005-05-05 2009-03-04 Valorisation Hsj Soc En Comman Cytokinrezeptor-modulatoren und verwendungen davon
US7671058B2 (en) 2006-06-21 2010-03-02 Institute Of Medicinal Molecular Design, Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1812595A (en) * 1994-02-28 1995-09-11 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Cell lines for the identification of substances affecting insulin receptor mediated signal transduction
EP0817967A4 (de) * 1995-03-31 2000-05-17 Merck & Co Inc Test für insulin nachahmende und verstärkende substanzen

Also Published As

Publication number Publication date
AU6026698A (en) 1998-08-07
JP2002512685A (ja) 2002-04-23
ES2242995T3 (es) 2005-11-16
DK0960335T3 (da) 2005-06-20
WO1998032017A2 (en) 1998-07-23
DE69830301T2 (de) 2006-02-02
WO1998032017A3 (en) 1999-02-25
EP0960335A2 (de) 1999-12-01
ATE296446T1 (de) 2005-06-15
CA2278023A1 (en) 1998-07-23
EP0960335B1 (de) 2005-05-25

Similar Documents

Publication Publication Date Title
DE69830301D1 (de) Modulatoren von insulinrezeptor-aktivität
Evans et al. The modulatory actions of FMRFamide and related peptides on locust skeletal muscle
Loewenstein et al. Separation of transducer and impulse-generating processes in sensory receptors
Nakamaru et al. Possible control of intracellular calcium metabolism by [H+]: sarcoplasmic reticulum of skeletal and cardiac muscle
Stanton et al. Epileptiform activity induced by lowering extracellular [Mg2+] in combined hippocampal-entorhinal cortex slices: modulation by receptors for norepinephrine and N-methyl-D-aspartate
Nagy Biophysical processes in invertebrate photoreceptors: recent progress and a critical overview based on Limulus photoreceptors
DE69534485D1 (de) Zyklische struktur-analoga von nervenwachstumfaktor (ngf) und deren verwendung
SE0003984D0 (sv) Adenosin A3-receptormodulatorer
DE60128551D1 (de) Geladene verbindungen mit einer nukleinsäure-bindenden einheit sowie deren verwendungen
DK0643775T3 (da) Quinonderivater til forbedring af cellebioenergi
Antunes-Madeira et al. Interaction of insecticides with the Ca2+-pump activity of sarcoplasmic reticulum
Warnick et al. Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
TR199901157T2 (xx) �nsektisid bile�imleri ve y�ntemleri
Siwicki et al. Proctolin in the lobster nervous system
Zhang et al. Secretagogue-induced mobilization of an intracellular Mg2+ pool in rat sublingual mucous acini.
Yoshida et al. Neural control of the buccal muscle movement in the African giant snail Achatina fulica
DE3685060D1 (de) Verwendung von kojic-saeure oder ihres beta-cyclodextrin-einschlusskomplexes zur praevention von elastosis.
Evans The effects of myomodulin and structurally related neuropeptides on skeletal neuromuscular transmission in the locust
DE58907554D1 (de) Phenoxyalkylsubstituierte Heteroaromaten, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Schädlingen.
AR037975A1 (es) El uso de antagonista del receptor h4 de histamina para el tratamiento de respuestas inflamatorias
Suarez-Kurtz The depolarizing afterpotential of crab muscle fibres. A sodium‐dependent process mediated by intracellular calcium.
Hunter et al. Norepinephrine release during vasoconstriction induced by cross-linked hemoglobin
EE9400180A (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu
IWASAKI Mononeuronal double innervation of an amphibian striated muscle fibre
WO2006102653A3 (en) Methods and compositions for treating insulin resistance and obesity-induced diseases

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee